Pharmacological treatment for the prevention of delirium: Review of current evidence

International Journal of Geriatric Psychiatry

Volumn 24, Issue 10, 2009, Pages 1037-1044

  Tabet, Naji ^a,b   Howard, Robert ^c  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b SUSSEX PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Delirium; Drugs; Intervention; Pharmacological; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DIAZEPAM; DONEPEZIL; FLUNITRAZEPAM; GABAPENTIN; HALOPERIDOL; HYPNOTIC AGENT; MELATONIN; NEUROLEPTIC AGENT; PETHIDINE; PLACEBO; RISPERIDONE; RIVASTIGMINE;

CLINICAL PROTOCOL; CLINICAL TRIAL; COCHRANE LIBRARY; CONTINUOUS INFUSION; DELIRIUM; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG USE; EMBASE; EVENING DOSAGE; EVIDENCE BASED MEDICINE; HEART SURGERY; HIP SURGERY; HUMAN; MEDLINE; MULTIINFARCT DEMENTIA; NONHUMAN; PATHOGENESIS; POSTOPERATIVE PERIOD; PRESCRIPTION; PROPHYLAXIS; REVIEW; SLEEP WAKING CYCLE;

AMINES; ANTI-INFLAMMATORY AGENTS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHOLINESTERASE INHIBITORS; CLINICAL TRIALS AS TOPIC; CYCLOHEXANECARBOXYLIC ACIDS; DELIRIUM; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPNOTICS AND SEDATIVES;

EID: 70350704993     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2220     Document Type: Review

References (61)

1. Aizawa K, Kanai T, Saikawa Y, et al. 2002. A novel approach to the prevention of postoperative delirium in the elderly after gastrointestinal surgery. Surg Today 32: 310-314. (Pubitemid 34671262)
2. Britton A, Russell R. 2004. Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment. Cochrane Database Syst Rev 2: CD000395.
3. Borovikova LV, Ivanova S, Zhang M, et al. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462. (Pubitemid 30367422)
4. Bourne RS, Mills GH. 2006. Melatonin: possible implications for the postoperative and critically ill patient. Intensive Care Med 32: 371-379.
5. Broadhurst C, Wilson K. 2001. Immunology of delirium: new opportunities for treatment and research. Br J Psychiatry 179: 288-289. (Pubitemid 32996036)
6. Carnes M, Howell T, Rosenberg M, et al. 2003. Physicians vary in approaches to the clinical management of delirium. J Am Geriatr Soc 51: 234-239. (Pubitemid 36205853)
7. Cole MG, You Y, McCusker J, et al. 2008. The 6 and 12 month outcomes of older medical inpatients who recover from delirium. Int J Geriatr Psychiatry 23: 301-317.
8. Dautzenberg PL, Mulder LJ, Olde Rikkert MG, et al. 2004. Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage. Int J Geriatr Psychiatry 19: 641-644.
9. Dautzenberg PL, Wouters CJ, Oudejans I, et al. 2003. Rivastigmine in prevention of delirium in a 65 years old man with Parkinson's disease. Int J Geriatr Psychiatry 18: 555-556. (Pubitemid 36763665)
10. Dowling GA, Burr RL, Van Someren EJ, et al. 2008. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 56: 239-246.
11. Fann JE. 2000. The epidemiology of delirium: a review of studies and methodological issues. Semin Clin Neuropsychiatry 5: 64-74.
12. Gaudreau JD, Gagnon P. 2005. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Med Hypotheses 64: 471-475. (Pubitemid 40023004)
13. Han CS, Kim YK. 2004. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45: 297-301. (Pubitemid 38823604)
14. Hanania M, Kitain E. 2002. Melatonin for treatment and prevention of postoperative delirium. Anesth Analg 94: 338-339. (Pubitemid 34106824)
15. Ho KY, Gan TJ, Habib AS. 2006. Gabapentin and postoperative pain - a systematic review of randomized controlled trials. Pain 126: 91-101. (Pubitemid 44751958)
16. Hshieh TT, Fong TG, Marcantonio ER, et al. 2008. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 63: 764-772.
17. Ikarashi Y, Takahashi A, Ishimaru H, et al. 1997. Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats. Brain Res Bull 43: 107-115. (Pubitemid 27265801)
18. Inouye SK, Bogardus ST Jr, Charpentier PA, et al. 1999. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340: 669-676. (Pubitemid 29110750)
19. Kales HC, Kamholz BA, Visnic SG, et al. 2003. Recorded delirium in a national sample of elderly inpatients: potential implications for recognition. J Geriatr Psychiatry Neurol 16: 32-38.
20. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. 2005. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 53: 1658-1666.
21. Kirshner HS. 2007. Delirium: a focused review. Curr Neurol Neurosci Rep 7: 479-482.
22. Kong VK, Irwin MG. 2007. Gabapentin: a multimodal perioperative drug? Br J Anaesth 99: 775-786.
23. Kulh MA, mumford VA, Sorensen R, et al. 2005. Management of delirium: a clinical governance approach. Aust Health Rev 29: 246-252.
24. Lemstra AW, Kalisvaart KJ, Vreeswijk R, et al. 2008. Pre-operative inflammatory markers and the risk of postoperative delirium in elderly patients. Int J Geriatr Psychiatry 23: 943-948.
25. Leslie DL, Zhang Y, Holford TR, et al. 2005. Premature death associated with delirium at 1-year follow up. Arch Intern Med 165: 1657-1662. (Pubitemid 41124162)
26. Leung JM, Sands LP, Rico M, et al. 2006. Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients. Neurology 67: 1251-1253. (Pubitemid 44563837)
27. Lindesay J. 1999. The concept of delirium. Dement Geriatr Cogn Disord 10: 310-314.
28. Lipowski ZJ. 1987. Delirium (acute confusional states). JAMA 258: 1789-1792.
29. Liptzin B, Laki A, Garb JL, et al. 2005. Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry 13: 1100-1106. (Pubitemid 46638655)
30. Marcantonio ER, Kiely DK, Simon SE, et al. 2005. Outcomes of older people admitted to postacute facilities with delirium. J Am Geriatr Soc 53: 963-969.
31. Meagher DJ. 2001. Delirium: optimising management. BMJ 322: 144-149.
32. Mistraletti G, Carloni E, Cigada M, et al. 2008. Sleep and delirium in the intensive care unit. Minerva Anestesiol 74: 329-333. (Pubitemid 352037800)
33. Moretti R, Torre P, Antonello RM, et al. 2004. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients. Am J Alzheimers Dis Other Demen 19: 333-339. (Pubitemid 39612925)
34. Minden SL, Carbone LA, Barsky A, et al. 2005. Predictors and outcomes of delirium. Gen Hosp Psychiatry 27: 209-214.
35. Ntais C, Pakos E, Kyzas P, et al. 2005. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 3: CD005063.
36. O'Keeffe S. 2002. The prevention of delirium. In Delirium in Old Age, Lindesay J, Rockwood K, Macdonald A (eds). Oxford University Press: Oxford; 153-185.
37. Olofsson K, Alling C, Lundberg D, et al. 2004. Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients. Acta Anaesthesiol Scand 48: 679-684. (Pubitemid 38843385)
38. Overshott R, Karim S, Burns A. 2008. Cholinesterase inhibitors for delirium. Cochrane Database Syst Rev 1: CD005317.
39. Pandharipande P, Shintani A, Peterson J, et al. 2006. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104: 21-26.
40. Pollak Y, Gilboa A, Ben-Menachem O, et al. 2005. Acetylcholinesterase inhibitors reduce brain and blood interleukin-1b production. Ann Neurol 57: 741-745. (Pubitemid 40628864)
41. Prakanrattana U, Prapaitrakool S. 2007. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 35: 714-719. (Pubitemid 47572095)
42. Ramirez-Bermudez J, Ruiz-Chow A, Perez-Neri I, et al. 2008. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium. Gen Hosp Psychiatry 30: 337-343. (Pubitemid 351862311)
43. Reale M, Iarlori C, Gambi F, et al. 2005. Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1β and interleukin-6 release from lymphocytes of Alzheimer's disease patients. Exp Gerontol 40: 165-171. (Pubitemid 40343007)
44. Riemersma-van der Lek RF, Swaab DF, Twisk J, et al. 2008. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 299: 2642-2655. (Pubitemid 351831594)
45. Saatman KE, Contreras PC, Smith DH, et al. 1997. Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury. Exp Neurol 147: 418-427.
46. Sampson EL, Raven PR, Ndhlovu PN, et al. 2007. A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int J Geriatr Psychiatry 22: 343-349.
47. Samuels SC, Evers MM. 2002. Pragmatic guidance for managing a common, confounding, and sometimes lethal condition. Geriatrics 57: 33-38.
48. Schrader SL,Wellik KE, Demaerschalk BM, et al. 2008. Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients. Neurologist 14: 134-137.
49. Seaman JS, Schillerstrom J, Carroll D, et al. 2006. Impaired oxidative metabolism precipitates delirium: a study of 101 ICU patients. Psychosomatics 47: 56-61. (Pubitemid 43017121)
50. Seitz DP, Gill SS, van Zyl LT. 2007. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 68: 11-21. (Pubitemid 46220119)
51. Shigeta H, Yasui A, Nimura Y, et al. 2001. Postoperative delirium and melatonin levels in elderly patients. Am J Surg 182: 449-454. (Pubitemid 34062839)
52. Shytle RD, Mori T, Townsend K, et al. 2004. Cholinergic modulation of microglial activation by α7 nicotinic receptors. J Neurochem 89: 337-343. (Pubitemid 38495982)
53. Sommer BR, Wise LC, Kraemer HC. 2002. Is dopamine administration possibly a risk factor for delirium? Crit Care Med 30: 1508-1511.
54. Tabet N. 2006. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing. Age Ageing 35: 336-338. (Pubitemid 43941799)
55. Tiippana EM, Hamunen K, Kontinen VK, et al. 2007. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg 104: 1545-1556. (Pubitemid 46791300)
56. Trzepacz PT. 2000. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 5: 132-148.
57. Uchida K, Aoki T, Ishizuka B. 1999. Postoperative delirium and plasma melatonin. Med Hypotheses 53: 103-106.
58. Van der Mast RC, Fekkes D, Moleman P, et al. 1991. Is postoperative delirium related to reduced plasma tryptophan? Lancet 338: 851-852.
59. Wang H, Yu M, Ochani M, et al. 2003. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421: 384-388. (Pubitemid 36157937)
60. Wilson K, Broadhurst C, Diver M, et al. 2005. Plasma insulin growth factor-1 and incident delirium in older people. Int J Geriatr Psychiatry 20: 154-159. (Pubitemid 40277894)
61. Zalsman G, Hermesh H, Munitz H. 1998. Alprazolam withdrawal delirium: a case report. Clin Neuropharmacol 21: 201-202. (Pubitemid 28248782)